Drug Discovery Market Research Reports & Industry Analysis
Drug discovery is the systematic process of identifying, designing, and developing new pharmaceutical compounds or therapies to treat specific diseases or medical conditions. This is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will yield products that achieve regulatory approval by the Food & Drug Administration (FDA). To help stakeholders navigate this complex market, MarketResearch.com offers a suite of comprehensive drug discovery reports on industries big and small.
Understanding the Drug Discovery Market
- Our compilation of reports features thousands of reports from leading research firms, allowing you to access highly targeted information.
- We provide a rich repository of data, including analysis of drug discovery market trends, forecasts, growth opportunities, and strategies.
- We also provide expert commentary on disruptive technologies and the use of artificial intelligence, machine learning, and blockchain in drug discovery.
Informed Insights: Your Path to Success
Whether you're an industry professional, a consultant, or an executive, our research collection provides credible data to help you make informed decisions that catalyze growth. For decades, we have served top pharmaceutical companies, investment banks, and consulting firms as a trusted research partner. Uncover new opportunities and stay ahead of the curve with MarketResearch.com's drug discovery industry reports.
Drug Discovery Industry Research & Market Reports
-
Drugs for Malaria Industry Research Report 2024
... temperate regions of the world. The disease is caused by a parasite, Plasmodium, which belongs to a group of one-celled organisms known as protozoa. The only way to get malaria is to be bitten by ... Read More
-
Recombinant Dna Technology Market, By Product Type (Recombinant Protein Drugs, Vaccines , Genetically Modified Crops, Cell and Gene Therapy, and Gene Editing), By Application (Therapeutics, Agriculture, Research, and Others), By End User (Biotechnology and Pharmaceutical Company, Diagnostic Laboratories, Academic and Government Institutes, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... Company, Diagnostic Laboratories, Academic and Government Institutes, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) Recombinant DNA technology is the joining together of DNA molecules from two different ... Read More
-
Global Acute Myeloid Leukemia Therapeutics Databank Market Report
... 5.19% from 2023 to 2031. Targeted Therapy and Immunotherapy segment is expected to be the highest contributor to this market, with $5,909.9 Million in 2022, and is anticipated to reach $8,938.5 Million by 2031, registering ... Read More
-
Global Insomnia Therapeutics Databank Market Report
... 2031. Drugs segment is expected to be the highest contributor to this market, with $3,103.4 Million in 2022, and is anticipated to reach $4,664.6 Million by 2031, registering a CAGR of 4.67%. Medical Devices segment ... Read More
-
Global Multiple Sclerosis Therapeutics Databank Market Report
... 2021 to 2029. Small-molecule Drugs segment is expected to be the highest contributor to this market, with $6,472.6 Million in 2020, and is anticipated to reach $12,240.1 Million by 2029, registering a CAGR of 7.38%. ... Read More
-
Global Myelodysplastic Syndrome Drugs Databank Market Report
... 2023 to 2031. Immunomodulatory Drugs segment is expected to be the highest contributor to this market, with $982.9 Million in 2022, and is anticipated to reach $2,003.9 Million by 2031, registering a CAGR of 8.28%. ... Read More
-
Global Investigational Drug CDMO Databank Market Report
... 2023 to 2031. Small Molecule segment is expected to be the highest contributor to this market, with $3,991.1 Million in 2022, and is anticipated to reach $6,166.8 Million by 2031, registering a CAGR of 5.00%. ... Read More
-
Global Liver Cancer Drugs Databank Market Report
... 2023 to 2031. Targeted Therapy segment is expected to be the highest contributor to this market, with $1,442.5 Million in 2022, and is anticipated to reach $4,029.6 Million by 2031, registering a CAGR of 12.16%. ... Read More
-
Global Myeloproliferative Disorders Drugs Databank Market Report
... 2023 to 2031. Ph+ CML segment is expected to be the highest contributor to this market, with $6,196.2 Million in 2022, and is anticipated to reach $7,194.7 Million by 2031, registering a CAGR of 1.71%. ... Read More
-
Global Idiopathic Pulmonary Fibrosis Treatment Databank Market Report
... 10.94% from 2021 to 2029. MAPK Inhibitors segment is expected to be the highest contributor to this market, with $1,304.4 Million in 2020, and is anticipated to reach $3,116.3 Million by 2029, registering a CAGR ... Read More
-
Post-operative Pain (POP) - Competitive Landscape
... the 16 countries covered in GlobalData’s epidemiology forecast for POP. Most marketed drugs for POP are enzyme inhibitors, followed by receptor agonists, by mechanism of action. Phase III pipeline for POP is robust and includes ... Read More
-
Friedreich Ataxia (FRDA) - Competitive Landscape
... in the 16 countries covered in GlobalData’s epidemiology forecast for FRDA. The marketed drugs space for FRDA is limited to just two approved drugs, Biogen's Skyclarys (omaveloxolone) is the leading drug in FRDA space. R&D ... Read More
-
Global Celiac Disease Drug Market Professional Survey by Types, Applications, and Players, with Regional Growth Rate Analysis and Development Situation, from 2023 to 2028
... growth of the Celiac Disease Drug industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Celiac Disease Drug. The report also introduces players ... Read More
-
Argentina Alzheimer's Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2032
... the report provides deep insights into demand forecasts, market trends, and, micro and macro indicators in the Argentina market. Also, factors that are driving and restraining the Alzheimer’s drugs market are highlighted in the study. ... Read More
-
New Prescription - Generative AI meets Healthcare (Vol. 2)
... generative AI within the pharmaceutical and healthcare sectors. This volume dives into recent real-world applications where generative AI is advancing across drug discovery, diagnostics, clinical documentation, and patient support. From harnessing vast datasets to expediting ... Read More
-
Reddit's Analysis on the Efficacy of Leading Weight Loss Drugs
... March 31st, 2024), offering a nuanced understanding of their prominence and positioning within the market, with detailed analysis of each of these top-mentioned weight loss drugs. It uncovers common discussion categories among Reddit users from ... Read More
-
Exosome Diagnostics, Therapeutics and Research Tools: Global Markets
... qualitative data, to help readers develop business/growth strategies, assess the market landscape, analyze their position in the current marketplace, and make informed business decisions regarding exosome products. BCC Research estimates market data for 2022 (the ... Read More
-
Global Oligonucleotide Therapeutics Market 2024-2028
... market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the ... Read More
-
Protein Sequencing Market Size, Trends, Analysis, and Outlook By Products and Services (Products, Services), By Application (Bio-therapeutics, Genetic Engineering, Others), By End-User (Academic Institutes & Research Centers, Pharmaceutical & Biotechnology Companies, Others), by Country, Segment, and Companies, 2024-2032
... and Companies, 2024-2032 The global Protein Sequencing market size is poised to register 4.1% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global ... Read More
-
Targeted Cancer Therapeutics Market Size, Trends, Analysis, and Outlook By Therapy (Small Molecule Drugs, Monoclonal Antibodies, Immunotherapies, Others), By Cancer (Lung Cancer, Breast Cancer, Colorectal Cancer, Blood Cancer, Gynecologic Cancer, Others), By End-User (Hospitals, Cancer and Radiation Therapy Centers, Specialty Clinics), by Country, Segment, and Companies, 2024-2032
... and Radiation Therapy Centers, Specialty Clinics), by Country, Segment, and Companies, 2024-2032 The global Targeted Cancer Therapeutics market size is poised to register 6.6% growth from 2024 to 2032, presenting significant growth prospects for companies ... Read More
-
Methicillin-Resistant Staphylococcus aureus (MRSA) Epidemiology Analysis and Forecast to 2033
... categorized according to the setting in which the infection was acquired, as either healthcare-associated MRSA (HA-MRSA), which is acquired in hospitals or in nursing homes, or community-associated MRSA (CA-MRSA) (CDC, 2019). MRSA remains highly prevalent ... Read More
-
Global Ebola Virus Infection Market - 2024-2031
... the forecast period 2024-2031. Ebola virus disease formerly known as ebola haemorrhagic fever is a severe often fatal illness affecting humans and other primates. The virus is transmitted to people from wild animals such as ... Read More
-
Alzheimer's Disease Diagnostics and Therapeutics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)
... is expected to reach USD 9.78 billion by 2029, growing at a CAGR of 5.06% during the forecast period (2024-2029). The emergence of the COVID-19 pandemic impacted the Alzheimer's disease diagnostics and therapeutics market, as ... Read More
-
Bioinformatics Market Size, Trends, Analysis, and Outlook By Products and Services (Knowledge Management Tools, Platforms, Services), By Application (Genomics, Chemo informatics & Drug Design, Proteomics, Transcriptomics, Metabolomics, Others), By Industry (Medical, Animal, Plant, Environmental, Forensic, Others), by Country, Segment, and Companies, 2024-2032
... Others), by Country, Segment, and Companies, 2024-2032 The global Bioinformatics market size is poised to register 12.3% growth from 2024 to 2032, presenting significant growth prospects for companies operating in the industry. The industry study ... Read More
-
Organoids Market Size, Trends, Analysis, and Outlook By Product (Intestine, Liver, Stomach, Pancrease, Others), By Application (Drug Discovery and Personalized Medicine, Drug Toxicity and Efficacy Testing, Regenerative Medicine, Developmental Biology, Others), By End-User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Research Institutes), by Country, Segment, and Companies, 2024-2032
... Biotechnology Companies, Contract Research Organizations, Research Institutes), by Country, Segment, and Companies, 2024-2032 The global Organoids market size is poised to register 15.3% growth from 2024 to 2032, presenting significant growth prospects for companies operating ... Read More
Research Assistance
